Celdaz 200 mg Injection
$4.62
$3.17
Celdaz 200 mg Injection is a targeted anticancer treatment designed to combat various malignancies, particularly advanced malignant melanoma, Hodgkin's lymphoma, and soft tissue sarcomas. This innovative medication works by inhibiting the growth of cancer cells, thereby helping to manage the progression of these serious conditions. However, it is essential to note that Celdaz is not recommended for pediatric patients, as its safety and effectiveness have not been thoroughly evaluated in children. Patients receiving Celdaz may experience side effects, including anemia, leukopenia, and thrombocytopenia, as well as a decrease in appetite, which should be monitored closely. Regular consultations with a healthcare provider are crucial to manage these potential risks effectively. By understanding how Celdaz works and its associated warnings, patients can better navigate their treatment journey. Always discuss with your physician to ensure that Celdaz is an appropriate choice for your specific cancer treatment needs. This injection represents a critical option in the fight against certain aggressive cancers, aiming to improve outcomes and enhance quality of life for those affected.
Quantity
Active Pharmaceutical Ingredient
Uses
• Celdaz 200 mg injection is primarily utilized in the treatment of malignant melanoma, a highly aggressive form of skin cancer. This medication targets the cancerous cells that originate from melanocytes, which are responsible for producing skin pigment. By employing Celdaz, healthcare providers aim to inhibit the growth and spread of these malignant cells. This treatment is crucial for improving patient outcomes in cases of advanced melanoma.
• Another important use of Celdaz 200 mg injection is in the management of Hodgkin's disease, a cancer affecting the lymphatic system. Patients with this condition often present with symptoms such as swollen lymph nodes and systemic signs like fever and night sweats. Celdaz helps to combat the abnormal cell proliferation characteristic of Hodgkin's lymphoma. Its role in therapy contributes to the overall treatment strategy for affected individuals.
• Celdaz 200 mg injection is also indicated for the treatment of soft tissue sarcomas, which arise from the body's soft tissues including muscles and fat. This type of cancer can be challenging to treat due to its diverse subtypes and locations in the body. By administering Celdaz, oncologists aim to effectively target and reduce the tumor mass. This approach is integral to providing comprehensive care for patients diagnosed with soft tissue sarcomas.
Benefits
Malignant melanoma is a type of skin cancer that develops in the pigment-producing cells of the skin, called melanocytes. It is the most dangerous form of skin cancer and can spread rapidly to other parts of the body if left untreated. Celdaz 200 mg Vial sticks to the genetic code, called DNA, of the cancer cells and kills them. It also prevents their growth and further spread. This helps to treat the cancer. Hodgkin’s disease is a type of lymphoma, which is a blood cancer that starts in the lymphatic system. The lymphatic system helps the immune system get rid of waste and fight infections. Dacarbazine Injection 200 mg kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Follow your doctor’s instructions carefully. Soft tissue sarcomas: Soft tissue sarcomas are a group of rare cancers that develop in the tissues that support and connect the body, such as muscles, tendons, fat, and blood vessels. They can occur anywhere in the body but are most commonly found in the limbs and trunk. Celdaz Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Follow your doctor’s instructions carefully.
Side Effects
Celdaz 200 mg may cause some side effects. If you experience any of these side effects contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Most Common Side Effects
• Hair loss
• Nausea
• Vomiting
• Diarrhea
• Sores throat
• Loss of appetite
• Burning or tingling effect on the face
Common Side Effects
• Skin rash
• Fever
• Muscle aches
• Difficulty in breathing or swallowing
How To Use
Celdaz Injection is given intravenously (IV), administered by a healthcare professional in a hospital or clinic setting. The specific dosing and administration of this medicine will depend on the clinical condition of the patient's age, medical history, and other factors. It is important to follow your doctor's instructions carefully when using this medication. Do not self-administer.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Celdaz 200 mg Vial. It may increase the risk of liver damage. It is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: patients with kidney disease should closely monitor kidney function while taking Celdaz 200 mg Injection and report any unusual symptoms or changes in kidney function to their physician. The dose of Celdaz 200 mg should be used with caution in patients with kidney disease. It is important to adjust the dose in patients with kidney disease.
• Breastfeeding: It is not recommended to breastfeed while taking Celdaz 200 mg. Celdaz 200 mg Injection may pass into breast milk and harm the infant. If you are breastfeeding and taking Dacarbazine Injection 200 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Anti-cancer Drug Celdaz should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Celdaz 200 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Celdaz 200 mg may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Dacarbazine Injection 200 mg may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Celdaz 200 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Celdaz 200 mg may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions, such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Celdaz Injection.